Lensar (LNSR) Amortizatization of Intangibles (2019 - 2026)
Lensar (LNSR) reported Amortizatization of Intangibles of $229000.0 for Q1 2026, up 65.94% year-over-year from $138000.0 in Q1 2025, and up 144.9% quarter-over-quarter from -$510000.0 in Q4 2025.
Lensar (LNSR) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Amortizatization of Intangibles data on file, last reported at $229000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $229000.0, up 65.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $178000.0 (down 87.17% YoY), and the FY2025 annual result was $181000.0, down 81.34% from the prior year.
- Amortizatization of Intangibles advanced to $229000.0 in Q1 2026 per LNSR's latest filing, from -$510000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $785000.0 in Q4 2024 and troughed at -$510000.0 in Q4 2025.
- A 5-year average of $203352.9 and a median of $230000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles surged 370.69% in 2024, then slumped 164.97% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $757000.0 in 2022, then sank by 138.31% to -$290000.0 in 2023, then surged by 370.69% to $785000.0 in 2024, then tumbled by 164.97% to -$510000.0 in 2025, then surged by 144.9% to $229000.0 in 2026.
- Business Quant data shows LNSR's Amortizatization of Intangibles at $229000.0 in Q1 2026, -$510000.0 in Q4 2025, and $229000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Lensar | 70.41 Mn | 70.70 Mn | 6.38 Mn | 229,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229,000.00 |
| Mar 31, 2026 | 229,000.00 |
| Dec 31, 2025 | -510,000.00 |
| Dec 31, 2025 | -510,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Jun 30, 2025 | 230,000.00 |
| Jun 30, 2025 | 230,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 785,000.00 |
| Dec 31, 2024 | 785,000.00 |
| Sep 30, 2024 | 232,000.00 |
| Sep 30, 2024 | 232,000.00 |
| Jun 30, 2024 | 232,000.00 |
| Jun 30, 2024 | 232,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | -290,000.00 |
| Dec 31, 2023 | -290,000.00 |